BECTON, DICKINSON AND COMPANY

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Prospective Clinical Evaluation of BD Spinal Needles

Completed

Conditions: Anesthesia
Analgesia

Interventions: Device: Spinal needle

First Posted Date: 2022-01-28

Last Posted Date: 2024-08-19

Lead Sponsor: Becton, Dickinson and Company

Target Recruit Count: 160

Registration Number: NCT05214560

Locations: 🇩🇪
Charité Campus Benjamin Franklin, Berlin, Germany
🇩🇪
Universitätsklinikum Leipzig, Leipzig, Germany
🇪🇸
Hospital Universitario Quirónsalud Madrid, Madrid, Spain

and more 3 locations

BD MiniDraw™ Capillary System Clinical Equivalence Study

Completed

Conditions: Healthy
Sample Collection
Acute Disease
Disease, Chronic

Interventions: Device: Capillary Blood Collection System

First Posted Date: 2022-01-11

Last Posted Date: 2023-11-03

Lead Sponsor: Becton, Dickinson and Company

Target Recruit Count: 262

Registration Number: NCT05186311

Locations: 🇺🇸
Babson Diagnostics, Austin, Texas, United States

An Observational Study to Evaluate BD PureHub™ Disinfecting Cap Use on Needle-Free Connectors

Completed

Conditions: Catheter Related Complication
Vascular Access Site Management
Disinfecting Cap

First Posted Date: 2021-11-23

Last Posted Date: 2023-06-18

Lead Sponsor: Becton, Dickinson and Company

Target Recruit Count: 157

Registration Number: NCT05130762

Locations: 🇦🇹
Medical University Vienna, Vienna, Austria
🇧🇪
UZA, Antwerp, Belgium
🇪🇸
Hospital Universitario de A Coruña, A Coruña, Spain

and more 2 locations

Evaluation of the BD OneFlow Acute Leukemia Panel on the BD FACSLyric Flow Cytometer

Completed

Conditions: Acute Leukemia

Interventions: Diagnostic Test: IUO Acute Leukemia Panel

First Posted Date: 2021-09-05

Last Posted Date: 2024-08-06

Lead Sponsor: Becton, Dickinson and Company

Target Recruit Count: 332

Registration Number: NCT05035615

Locations: 🇺🇸
New York-Presbyterian Hospital Weill Cornell Medicine, New York, New York, United States
🇺🇸
Childrens Hospital Los Angeles, Los Angeles, California, United States
🇨🇿
Motol University Hospital, Childhood Leukemia Investigation, Prague, Czechia

and more 5 locations

Evaluation of the Chronic Lymphoproliferative Diseases Limited Panel on the BD FACSLyric™ Flow Cytometer

Completed

Conditions: Chronic Lymphoproliferative Diseases (CLPD)

Interventions: Diagnostic Test: IUO CLPD Limited Panel

First Posted Date: 2021-09-02

Last Posted Date: 2024-02-28

Lead Sponsor: Becton, Dickinson and Company

Target Recruit Count: 371

Registration Number: NCT05032313

Locations: 🇺🇸
Corepath Laboratories, San Antonio, Texas, United States
🇬🇧
Cambridge university hospital, Cambridge, United Kingdom
🇺🇸
University of North Carolina, Chapel Hill, North Carolina, United States

and more 3 locations

Evaluation of the Plasma Cell Disorders Panel on the BD FACSLyric™ Flow Cytometer

Completed

Conditions: Plasma Cell Disorder

Interventions: Diagnostic Test: IUO Plasma Cell Disorders Panel

First Posted Date: 2021-09-02

Last Posted Date: 2023-10-30

Lead Sponsor: Becton, Dickinson and Company

Target Recruit Count: 208

Registration Number: NCT05032339

Locations: 🇬🇧
Cambridge university hospital, Cambridge, United Kingdom
🇺🇸
Corepath Laboratories, San Antonio, Texas, United States
🇪🇸
University of Salamanca, Salamanca, Spain

and more 2 locations

A 7 Day Adhesive Device Wear Study to Evaluate BD StatLock™ Devices

Completed

Conditions: Peripheral Intravenous Catheter Stabilization

Interventions: Device: StatLock™ Catheter Stabilization Device and the StatLock™ stabilization device accessory (Foam Strip)

First Posted Date: 2021-04-15

Last Posted Date: 2021-09-08

Lead Sponsor: Becton, Dickinson and Company

Target Recruit Count: 120

Registration Number: NCT04845906

Locations: 🇺🇸
TKL Research, Inc, Fair Lawn, New Jersey, United States
🇺🇸
Dermico, LLC, Broomall, Pennsylvania, United States

Prospective Healthy Volunteer Study of the Securis™ Stabilization Device

Completed

Conditions: Peripheral Intavenous Catheter Stabilization

Interventions: Device: Securis™ Stabilization Device

First Posted Date: 2021-04-12

Last Posted Date: 2021-09-08

Lead Sponsor: Becton, Dickinson and Company

Target Recruit Count: 104

Registration Number: NCT04841330

Locations: 🇺🇸
TKL Research, Inc, Fair Lawn, New Jersey, United States

Efficiency, and Emergency Department Nurse Preference Between 2 Methods of Visualization: A Pilot Study

Completed

Conditions: Catheter Related Complication

Interventions: Device: Randomized Traditional
Device: Cue(TM) Needle Tracking Technology

First Posted Date: 2021-03-23

Last Posted Date: 2021-03-23

Lead Sponsor: Becton, Dickinson and Company

Target Recruit Count: 49

Registration Number: NCT04811430

Locations: 🇺🇸
Austin Convention Center, Austin, Texas, United States

Capturing Infectious COVID-19 Asymptomatic Cases in Singapore

Withdrawn

Conditions: SARS CoV-2
Covid19

Interventions: Diagnostic Test: BD Veritor Plus System for Rapid Detection of SARS CoV-2
Diagnostic Test: rt-PCR
Diagnostic Test: viral culture

First Posted Date: 2021-03-23

Last Posted Date: 2021-08-11

Lead Sponsor: Becton, Dickinson and Company

Registration Number: NCT04812327

Locations: 🇸🇬
Changi General Hospital, Singapore, Singapore

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy